1 of 1
Story summary
- European drugmakers’ chairs urged the EU and member states to boost medicine investment.
- Their share of pharma R&D in Europe fell to 31% from 43% in 1990.
- Approved medicines now take an average 600 days to reach European patients.
- The United States and China announced over $600 bn of pharma investment in the past two years.